Michael W. Boesgaard

551 total citations
13 papers, 467 citations indexed

About

Michael W. Boesgaard is a scholar working on Molecular Biology, Oncology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Michael W. Boesgaard has authored 13 papers receiving a total of 467 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Oncology and 5 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Michael W. Boesgaard's work include Receptor Mechanisms and Signaling (6 papers), Cancer Treatment and Pharmacology (6 papers) and Chemotherapy-induced cardiotoxicity and mitigation (5 papers). Michael W. Boesgaard is often cited by papers focused on Receptor Mechanisms and Signaling (6 papers), Cancer Treatment and Pharmacology (6 papers) and Chemotherapy-induced cardiotoxicity and mitigation (5 papers). Michael W. Boesgaard collaborates with scholars based in Denmark, New Zealand and China. Michael W. Boesgaard's co-authors include P Dombernowsky, Benny Vittrup Jensen, Julie Gehl, Hans Bräuner‐Osborne, Christina Rye Underwood, Hang Zhang, Xiao‐Feng Xiong, David E. Gloriam, Kristian Strømgaard and Elo Andersen and has published in prestigious journals such as Journal of Biological Chemistry, Bioinformatics and Scientific Reports.

In The Last Decade

Michael W. Boesgaard

13 papers receiving 460 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael W. Boesgaard Denmark	11	268	130	117	108	49	13	467
Tomás G. Lyons United States	10	219 0.8×	219 1.7×	16 0.1×	96 0.9×	13 0.3×	18	442
Roberto Diaz United States	9	118 0.4×	104 0.8×	12 0.1×	136 1.3×	19 0.4×	24	354
Marta Vallee Cobham United States	6	114 0.4×	88 0.7×	37 0.3×	39 0.4×	6 0.1×	7	225
L. Orlandi Italy	13	232 0.9×	298 2.3×	10 0.1×	73 0.7×	8 0.2×	32	486
Hanan Ahmed Wahba Egypt	8	238 0.9×	226 1.7×	8 0.1×	140 1.3×	5 0.1×	24	529
Chaplin Dj Canada	10	64 0.2×	140 1.1×	14 0.1×	166 1.5×	9 0.2×	18	411
Alexander Jorge Cortez Poland	10	238 0.9×	332 2.6×	20 0.2×	186 1.7×	2 0.0×	24	696
Chiara Barozzi Italy	13	130 0.5×	224 1.7×	104 0.9×	74 0.7×		25	534
Wen‐Bin Ho United States	11	44 0.2×	309 2.4×	25 0.2×	150 1.4×	4 0.1×	13	554
Thomas-Toan Tran United States	8	262 1.0×	296 2.3×	19 0.2×	34 0.3×	5 0.1×	10	541

Countries citing papers authored by Michael W. Boesgaard

Since Specialization

Citations

This map shows the geographic impact of Michael W. Boesgaard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael W. Boesgaard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael W. Boesgaard more than expected).

Fields of papers citing papers by Michael W. Boesgaard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael W. Boesgaard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael W. Boesgaard. The network helps show where Michael W. Boesgaard may publish in the future.

Co-authorship network of co-authors of Michael W. Boesgaard

This figure shows the co-authorship network connecting the top 25 collaborators of Michael W. Boesgaard. A scholar is included among the top collaborators of Michael W. Boesgaard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael W. Boesgaard. Michael W. Boesgaard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Boesgaard, Michael W., Kasper Harpsøe, Christina Rye Underwood, et al.. (2020). Delineation of molecular determinants for FR900359 inhibition of Gq/11 unlocks inhibition of Gαs. Journal of Biological Chemistry. 295(40). 13850–13861. 14 indexed citations

Xiong, Xiao‐Feng, Hang Zhang, Michael W. Boesgaard, et al.. (2019). Structure–Activity Relationship Studies of the Natural Product G_q/11 Protein Inhibitor YM‐254890. ChemMedChem. 14(8). 865–870. 18 indexed citations

Zhang, Hang, Alexander L. Nielsen, Michael W. Boesgaard, et al.. (2018). Structure–activity relationship and conformational studies of the natural product cyclic depsipeptides YM-254890 and FR900359. European Journal of Medicinal Chemistry. 156. 847–860. 27 indexed citations

Boesgaard, Michael W., Alexander S. Hauser, Vignir Ísberg, et al.. (2017). Identification of Histamine H3 Receptor Ligands Using a New Crystal Structure Fragment-based Method. Scientific Reports. 7(1). 4829–4829. 8 indexed citations

Zhang, Hang, Xiao‐Feng Xiong, Michael W. Boesgaard, et al.. (2017). Structure–Activity Relationship Studies of the Cyclic Depsipeptide Natural Product YM‐254890, Targeting the G_q Protein. ChemMedChem. 12(11). 830–834. 24 indexed citations

Harpsøe, Kasper, Michael W. Boesgaard, Christian Munk, Hans Bräuner‐Osborne, & David E. Gloriam. (2016). Structural insight to mutation effects uncover a common allosteric site in class C GPCRs. Bioinformatics. 33(8). 1116–1120. 10 indexed citations

Johansson, Henrik, et al.. (2015). Selective Allosteric Antagonists for the G Protein-Coupled Receptor GPRC6A Based on the 2-Phenylindole Privileged Structure Scaffold. Journal of Medicinal Chemistry. 58(22). 8938–8951. 18 indexed citations

Dombernowsky, P, Michael W. Boesgaard, Elo Andersen, & Benny Vittrup Jensen. (1997). Doxorubicin plus paclitaxel in advanced breast cancer.. PubMed. 24(5 Suppl 17). S17–15. 23 indexed citations

Gehl, Julie, et al.. (1996). Combined doxorubicin and paclitaxel in advanced breast cancer: Effective and cardiotoxic. Annals of Oncology. 7(7). 687–693. 220 indexed citations

10.

Dombernowsky, P, et al.. (1996). Doxorubicin and paclitaxel, a highly active combination in the treatment of metastatic breast cancer.. PubMed. 23(5 Suppl 11). 23–7. 59 indexed citations

11.

Gehl, Julie, et al.. (1996). Paclitaxel and doxorubicin in metastatic breast cancer.. PubMed. 23(6 Suppl 15). 35–8. 9 indexed citations

12.

Dombernowsky, P, Julie Gehl, Michael W. Boesgaard, Thomas Wiben Jensen, & Benny Vittrup Jensen. (1996). Paclitaxel and doxorubicin, a highly active combination in the treatment of metastatic breast cancer.. PubMed. 23(1 Suppl 1). 13–8. 18 indexed citations

13.

Dombernowsky, P, et al.. (1995). Treatment of metastatic breast cancer with paclitaxel and doxorubicin.. PubMed. 22(6 Suppl 15). 13–7. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact